Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, Mar 1996, 233-235, Vol 3, No. 2
WV Kern, J Oristrell, F Segura-Porta and P Kern
Tumor necrosis factor alpha (TNF) is a key cytokine in the defense against
many intracellular pathogens, including Rickettsia conorii, the causative
agent of Mediterranean spotted fever (MSF). The levels of two soluble TNF
receptors (sTNFR-p55 and sTNFR-p75), the extracellular domains of the two
cell surface receptors for TNF, were elevated in the acute-stage plasma
samples from 20 patients with serologically confirmed MSF. The median
values were 3.1 and 7.8 ng/ml for sTNFR-p55 and sTNFR-p75, respectively.
sTNFR values correlated significantly with plasma TNF concentrations.
Patients with severe MSF had higher values for both receptor fragments than
patients with nonsevere disease. The differences were statistically
significant for sTNFR-p55 (median, 5.8 versus 2.0 ng/ml; P = 0.008). Given
the proportionately higher values for both TNF and sTNFR-p55 in patients
with severe MSF, the sTNFR- p55/TNF ratios for the two patient subgroups
did not differ (P = 0.5), while the sTNFR-p75/TNF ratios were significantly
different (P = 0.01), with disproportionately lower values in patients with
severe disease.
Copyright © 1996 by the American Society for Microbiology. All rights reserved.
Release of soluble tumor necrosis factor receptors in Mediterranean spotted fever rickettsiosis
Section of Infectious Diseases and Clinical Immunology, University Hospital, Ulm, Germany.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |